Skip to content
10-Q

Quarterly Report

Tobira Therapeutics, Inc.

0001564590-15-007001

← back to feed
Filed
Aug 11, 2015 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · Aug 7, 2015 17.44M sh
Long Term Debt Q2 2015 · Jun 30, 2015 $12.46M
Long Term Debt Q2 2015 · Dec 31, 2014 $14.79M
Stockholders Equity Q2 2015 · Jun 30, 2015 $58.14M
Stockholders Equity Q2 2015 · Dec 31, 2014 −$109.38M
Current Liabilities Q2 2015 · Jun 30, 2015 $9.65M
Current Liabilities Q2 2015 · Dec 31, 2014 $38.24M
Total Liabilities Q2 2015 · Jun 30, 2015 $26.7M
Total Liabilities Q2 2015 · Dec 31, 2014 $55.75M
Current Assets Q2 2015 · Jun 30, 2015 $65.11M
Current Assets Q2 2015 · Dec 31, 2014 $7.19M
Total Assets Q2 2015 · Jun 30, 2015 $84.84M
Total Assets Q2 2015 · Dec 31, 2014 $8.35M
Capex restated Q2 2015 · Jun 30, 2014 $63K
Cash And Equivalents restated Q2 2015 · Jun 30, 2014 $18.76M
Cash And Equivalents restated Q2 2015 · Dec 31, 2013 $4.09M
Sga Expense restated Q2 2015 · Jun 30, 2014 $1.87M
Sga Expense restated Q2 2015 · Jun 30, 2014 $2.74M
Rd Expense restated Q2 2015 · Jun 30, 2014 $3.09M
Rd Expense restated Q2 2015 · Jun 30, 2014 $4.76M
Net Income restated Q2 2015 · Jun 30, 2014 −$7.92M
Net Income restated Q2 2015 · Jun 30, 2014 −$10.75M
Operating Income restated Q2 2015 · Jun 30, 2014 −$4.97M
Operating Income restated Q2 2015 · Jun 30, 2014 −$7.51M